Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
73.25
+0.24 (0.33%)
At close: Mar 28, 2024, 4:00 PM
73.39
+0.14 (0.19%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 85.85, with a low estimate of 71 and a high estimate of 105. The average target predicts an increase of 17.20% from the current stock price of 73.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 3 | 3 | 3 | 2 | 2 |
Buy | 5 | 3 | 3 | 3 | 3 | 3 |
Hold | 6 | 7 | 7 | 6 | 7 | 7 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 14 | 14 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold Maintains $84 → $77 | Hold | Maintains | $84 → $77 | +5.12% | Mar 4, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $101 → $90 | Strong Buy | Maintains | $101 → $90 | +22.87% | Feb 22, 2024 |
Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $91 → $82 | Strong Buy → Hold | Downgrades | $91 → $82 | +11.95% | Feb 22, 2024 |
RBC Capital | RBC Capital | Hold Maintains $76 → $75 | Hold | Maintains | $76 → $75 | +2.39% | Feb 14, 2024 |
Barclays | Barclays | Hold Maintains $85 → $80 | Hold | Maintains | $85 → $80 | +9.22% | Feb 12, 2024 |
Financial Forecast
Revenue This Year
28.04B
from 27.12B
Increased by 3.40%
Revenue Next Year
28.59B
from 28.04B
Increased by 1.97%
EPS This Year
7.24
from 4.50
Increased by 60.84%
EPS Next Year
7.58
from 7.24
Increased by 4.68%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 29.4B | 30.7B | 31.9B | 36.3B | 38.2B |
Avg | 28.0B | 28.6B | 29.4B | 30.6B | 31.2B |
Low | 26.5B | 26.7B | 26.9B | 26.8B | 26.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.5% | 9.4% | 11.7% | 23.3% | 25.0% |
Avg | 3.4% | 2.0% | 2.9% | 3.9% | 2.1% |
Low | -2.1% | -4.8% | -6.1% | -9.0% | -12.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.40 | 8.66 | 9.07 | 10.97 | 11.55 |
Avg | 7.24 | 7.58 | 7.92 | 8.45 | 8.95 |
Low | 6.71 | 6.48 | 6.69 | 6.92 | 7.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 86.7% | 19.7% | 19.7% | 38.5% | 36.6% |
Avg | 60.8% | 4.7% | 4.6% | 6.7% | 5.8% |
Low | 49.2% | -10.5% | -11.7% | -12.7% | -14.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.